ketoconazole has been researched along with AIDS-Related Opportunistic Infections in 70 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This randomized comparative study assessed the efficacy and safety of a 10-mg once-daily topical regimen of miconazole nitrate mucoadhesive buccal tablet (n = 178) versus a 400-mg once-daily systemic regimen of ketoconazole (n = 179) in HIV-positive patients with oropharyngeal candidiasis." | 9.11 | Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. ( Haxaire, M; Kamya, M; Katabira, E; Lwanga, I; Van Roey, J, 2004) |
| "To assess the efficacy and safety of itraconazole in preventing relapse of histoplasmosis after induction therapy with amphotericin B in patients with the acquired immunodeficiency syndrome (AIDS) and disseminated histoplasmosis." | 9.07 | Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. ( Briggs, N; Connolly-Stringfield, P; Hafner, R; Hamill, R; Murphy, R; Owens, S; Powderly, W; Rinaldi, M; Saag, M; Spencer, P; Squires, K; Wheat, J; Wong, B; Wulfsohn, M, 1993) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 7.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 5.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| "This randomized comparative study assessed the efficacy and safety of a 10-mg once-daily topical regimen of miconazole nitrate mucoadhesive buccal tablet (n = 178) versus a 400-mg once-daily systemic regimen of ketoconazole (n = 179) in HIV-positive patients with oropharyngeal candidiasis." | 5.11 | Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis. ( Haxaire, M; Kamya, M; Katabira, E; Lwanga, I; Van Roey, J, 2004) |
| "After the first episode of esophageal candidiasis, 122 consecutive AIDS patients were randomly assigned to two different regimens of continuous long-term antifungal prophylaxis (ketoconazole 200 mg or fluconazole 50 mg/day p." | 5.07 | Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. ( Antinori, S; Ardizzone, S; Bianchi Porro, G; Cernuschi, M; Esposito, R; Lazzarin, A; Moroni, M; Parente, F, 1994) |
| "To assess the efficacy and safety of itraconazole in preventing relapse of histoplasmosis after induction therapy with amphotericin B in patients with the acquired immunodeficiency syndrome (AIDS) and disseminated histoplasmosis." | 5.07 | Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. ( Briggs, N; Connolly-Stringfield, P; Hafner, R; Hamill, R; Murphy, R; Owens, S; Powderly, W; Rinaldi, M; Saag, M; Spencer, P; Squires, K; Wheat, J; Wong, B; Wulfsohn, M, 1993) |
| "A systematic review of randomized clinical trials published between 1966 and April 2000 was undertaken to determine the strength of evidence for the effectiveness of antifungal drugs (nystatin, clotrimazole, amphotericin B, fluconazole, ketoconazole, and itraconazole) to prevent and treat oral candidiasis in human immunodeficiency virus-positive patients." | 4.81 | A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. ( Bonito, AJ; Patton, LL; Shugars, DA, 2001) |
| " Benznidazole, the drug generally used for the treatment of Chagas disease, was initially used in one case but discontinued because of an adverse effect (retrobulbar neuritis) and replaced by itraconazole." | 3.75 | Aetiological treatment with itraconazole or ketoconazole in individuals with Trypanosoma cruzi/HIV co-infection. ( Aoki, FH; de Almeida, EA; Guariento, ME; Pedro, Rde J; Silva, EL, 2009) |
| "In our study 77 AIDS patients suffering from oral and/or esophageal candidiasis were evaluated: 38 received fluconazole, 39 ketoconazole." | 3.68 | Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients. ( Ancarani, F; Arzeni, D; Barchiesi, F; Branchesi, P; Crescenzi, G; Giacometti, A; Scalise, G, 1992) |
| "Oral candidiasis is one of the common diseases seen in HIV/AIDS patients." | 2.73 | Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria. ( Chukwuneke, F; Oji, C, 2008) |
| "Twelve HIV-infected patients were assigned into a one-sequence, two-period pharmacokinetic interaction study." | 2.73 | Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients. ( Jaruratanasirikul, S; Mahatthanatrakul, W; Ridtitid, W; Sriwiriyajan, S, 2007) |
| " Twenty-four subjects received oral fluconazole in a dosage of 3 mg/kg/day and 22 subjects received oral ketoconazole in a dosage of 7 mg/kg/day." | 2.67 | Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group. ( Hernández-Sampelayo, T, 1994) |
| "American pulmonary histoplasmosis is a deep mycosis imported from North America caused by the inhalation of Histoplasma capsulatum." | 2.40 | [American pulmonary histoplasmosis caused by Histoplasma capsulatum]. ( Bonnet, D; Cuguillière, A; Guigay, J; Jancovici, R; L'Her, P; Le Vagueresse, R; Lonjon, T; Miltgen, J; Natali, E; Vaylet, F, 1998) |
| "Ketoconazole tablets were used with good success in previous years of the AIDS epidemics." | 2.39 | [Therapy of candidiasis and cryptococcosis in AIDS]. ( Just-Nübling, G, 1994) |
| " glabrata was less susceptible (4-8 mg/l) or resistant (> 8 mg/l) to fluconazole and resistant to itraconazole and ketoconazole High dosed intravenous fluconazole treatment with 400 to 600 mg daily failed in 11 patients with fluconazole resistant C." | 1.30 | [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole]. ( Hofmann, H; Metzger, S, 1997) |
| "Histoplasmosis is an important cause of morbidity and death in HIV-infected patients." | 1.30 | Histoplasmosis: update 1998. ( Brooks, JT; Wheat, LJ, 1998) |
| "Histoplasmosis is a fungal infection caused by the organism Histoplasma capsulatum." | 1.29 | Oral histoplasmosis in HIV-infected patients. A report of two cases. ( Chernoff, DN; Chinn, H; Green, TL; Migliorati, CA; Silverman, S, 1995) |
| "Ketoconazole was most often used for presumed or documented oral, urogenital, or esophageal infections and amphotericin B was the preferred agent for disseminated infections and fungemia (p < 0." | 1.29 | Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole. ( Goodwin, SD; Grasela, TH; Pasko, MT; Raebel, MA; Walawander, CA, 1994) |
| "Persons with hemophilia who receive multiple blood product transfusions from blood banks with little or no screening for infectious agents are at particularly high risk for infections with both HIV and T." | 1.29 | Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS. ( Acuña, G; Brengues, C; Cuny, G; Labarca, J; Muñoz, S; Oddó, D; Saavedra, H; Sepúlveda, C; Solari, A; Veas, F, 1993) |
| "Treatment with fluconazole, 200 mg/day, was introduced." | 1.29 | [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. ( Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 51 (72.86) | 18.2507 |
| 2000's | 19 (27.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, FM | 1 |
| Staudigel, A | 1 |
| Salvenmoser, S | 1 |
| Tredup, A | 1 |
| Miltenberger, R | 1 |
| Herrmann, JV | 1 |
| Nadagir, SD | 1 |
| Chunchanur, SK | 1 |
| Halesh, LH | 1 |
| Yasmeen, K | 1 |
| Chandrasekhar, MR | 1 |
| Patil, BS | 1 |
| Oji, C | 1 |
| Chukwuneke, F | 1 |
| de Almeida, EA | 1 |
| Silva, EL | 1 |
| Guariento, ME | 1 |
| Aoki, FH | 1 |
| Pedro, Rde J | 1 |
| Tacconelli, E | 2 |
| Bertagnolio, S | 1 |
| Posteraro, B | 2 |
| Tumbarello, M | 2 |
| Boccia, S | 1 |
| Fadda, G | 1 |
| Cauda, R | 2 |
| Van Roey, J | 1 |
| Haxaire, M | 1 |
| Kamya, M | 1 |
| Lwanga, I | 1 |
| Katabira, E | 1 |
| Clyti, E | 1 |
| Sayavong, K | 1 |
| Monchy, D | 1 |
| Chanthavisouk, K | 1 |
| Rincón, S | 1 |
| Cepero de García, MC | 1 |
| Espinel-Ingroff, A | 2 |
| Sriwiriyajan, S | 1 |
| Mahatthanatrakul, W | 1 |
| Ridtitid, W | 1 |
| Jaruratanasirikul, S | 1 |
| Just-Nübling, G | 1 |
| Chinn, H | 1 |
| Chernoff, DN | 1 |
| Migliorati, CA | 1 |
| Silverman, S | 2 |
| Green, TL | 1 |
| Lamb, DC | 1 |
| Corran, A | 1 |
| Baldwin, BC | 1 |
| Kwon-Chung, J | 1 |
| Kelly, SL | 1 |
| Denning, DW | 1 |
| Opocher, G | 1 |
| Mantero, F | 1 |
| Hernández-Sampelayo, T | 1 |
| Parente, F | 1 |
| Ardizzone, S | 1 |
| Cernuschi, M | 1 |
| Antinori, S | 1 |
| Esposito, R | 1 |
| Moroni, M | 1 |
| Lazzarin, A | 1 |
| Bianchi Porro, G | 1 |
| Grasela, TH | 1 |
| Goodwin, SD | 1 |
| Pasko, MT | 1 |
| Walawander, CA | 1 |
| Raebel, MA | 1 |
| Graybill, JR | 1 |
| Heinic, GS | 1 |
| Stevens, DA | 1 |
| Greenspan, D | 2 |
| MacPhail, LA | 2 |
| Dodd, CL | 1 |
| Stringari, S | 1 |
| Strull, WM | 1 |
| Hollander, H | 1 |
| Drew, RH | 1 |
| Solari, A | 1 |
| Saavedra, H | 1 |
| Sepúlveda, C | 1 |
| Oddó, D | 1 |
| Acuña, G | 1 |
| Labarca, J | 1 |
| Muñoz, S | 1 |
| Cuny, G | 1 |
| Brengues, C | 1 |
| Veas, F | 1 |
| Wheat, J | 1 |
| Hafner, R | 1 |
| Wulfsohn, M | 1 |
| Spencer, P | 1 |
| Squires, K | 1 |
| Powderly, W | 1 |
| Wong, B | 1 |
| Rinaldi, M | 1 |
| Saag, M | 1 |
| Hamill, R | 1 |
| Murphy, R | 1 |
| Connolly-Stringfield, P | 1 |
| Briggs, N | 1 |
| Owens, S | 1 |
| Pelloux, H | 1 |
| Lebeau, B | 1 |
| Manquat, G | 1 |
| Leclercq, P | 1 |
| Blanc, M | 1 |
| Ambroise-Thomas, P | 1 |
| Grillot, R | 1 |
| Meyer, C | 1 |
| Piketty, C | 1 |
| George, F | 1 |
| Weiss, L | 1 |
| Lavarde, V | 1 |
| Hernigou, A | 1 |
| Kazatchkine, MD | 1 |
| Lortholary, O | 2 |
| Meyohas, MC | 1 |
| Dupont, B | 2 |
| Cadranel, J | 1 |
| Salmon-Ceron, D | 1 |
| Peyramond, D | 1 |
| Simonin, D | 1 |
| Berman, DS | 1 |
| Wenglin, BD | 1 |
| St-Germain, G | 1 |
| Dion, C | 1 |
| Ratelle, J | 1 |
| de Repentigny, L | 1 |
| Johnson, EM | 1 |
| Warnock, DW | 1 |
| Eichmann, A | 1 |
| Schär, G | 1 |
| Tebbe, B | 1 |
| Boyvat, A | 1 |
| Geilen, CC | 1 |
| Wölfer, LU | 1 |
| Seibold, M | 1 |
| Orfanos, CE | 1 |
| Gallo, JW | 1 |
| McKnight, ML | 1 |
| Mayer, P | 1 |
| deSanz, S | 1 |
| Tan, MM | 1 |
| Caldarola, G | 1 |
| Morace, G | 1 |
| Ortona, L | 1 |
| Taylor, CB | 1 |
| Finlay, R | 1 |
| Richardson, C | 1 |
| Bunting, P | 1 |
| Welch, J | 1 |
| Zeldis, JB | 1 |
| Nittayananta, W | 2 |
| Kumplanont, P | 1 |
| Srisintorn, S | 1 |
| Akkayanont, P | 1 |
| Chungpanich, S | 1 |
| Teanpaisan, R | 2 |
| Chareonwatanan, M | 1 |
| Nuntanaranont, T | 1 |
| White, TC | 2 |
| Diz Dios, P | 1 |
| Vázquez García, E | 1 |
| Cartledge, JD | 3 |
| Midgley, J | 3 |
| Gazzard, BG | 3 |
| Hamide, A | 1 |
| Dutta, TK | 1 |
| Vasireddy, S | 1 |
| Ustianowski, AP | 1 |
| Leake, H | 1 |
| Evans, S | 1 |
| Petrou, M | 1 |
| Shanson, D | 1 |
| Metzger, S | 1 |
| Hofmann, H | 1 |
| Fortun Abete, J | 1 |
| Odds, FC | 1 |
| Laing, RB | 1 |
| Brettle, RP | 1 |
| Leen, CL | 1 |
| Sanders, CJ | 1 |
| Ellepola, AN | 3 |
| Samaranayake, LP | 4 |
| Nébavi, F | 1 |
| Arnavielhe, S | 1 |
| Le Guennec, R | 1 |
| Ménan, E | 1 |
| Kacou, A | 1 |
| Combe, P | 1 |
| Aoussi, E | 1 |
| Mallié, M | 1 |
| Koné, M | 1 |
| Bastide, JM | 1 |
| Terrell, CL | 1 |
| Guigay, J | 1 |
| Cuguillière, A | 1 |
| Miltgen, J | 1 |
| Lonjon, T | 1 |
| Jancovici, R | 1 |
| Vaylet, F | 1 |
| Natali, E | 1 |
| Le Vagueresse, R | 1 |
| Bonnet, D | 1 |
| L'Her, P | 1 |
| Chongsuvivatwong, V | 1 |
| Govender, S | 1 |
| Mutasa, E | 1 |
| Parbhoo, AH | 1 |
| Nenoff, P | 1 |
| Reinl, P | 1 |
| Haustein, UF | 1 |
| Walmsley, S | 1 |
| King, S | 1 |
| McGeer, A | 1 |
| Ye, Y | 1 |
| Richardson, S | 1 |
| Barr, D | 1 |
| Smart, T | 1 |
| Brooks, JT | 1 |
| Wheat, LJ | 1 |
| Briand, V | 1 |
| Samaranayake, YH | 1 |
| Tsang, PC | 1 |
| Wong, KH | 1 |
| Yeung, KW | 1 |
| Patton, LL | 1 |
| Bonito, AJ | 1 |
| Shugars, DA | 1 |
| Anil, S | 1 |
| Sant'Ana, Pde L | 1 |
| Milan, EP | 1 |
| Martinez, R | 1 |
| Queiroz-Telles, F | 1 |
| Ferreira, MS | 1 |
| Alcântara, AP | 1 |
| Carvalho, MT | 1 |
| Colombo, AL | 1 |
| Barchiesi, F | 1 |
| Giacometti, A | 1 |
| Arzeni, D | 1 |
| Branchesi, P | 1 |
| Crescenzi, G | 1 |
| Ancarani, F | 1 |
| Scalise, G | 1 |
| Jones, PD | 1 |
| See, J | 1 |
| Miyasaki, SH | 1 |
| Hicks, JB | 1 |
| Polacheck, I | 1 |
| Agabian, N | 1 |
| Greenspan, JS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study to Determine the Feasibility of Itraconazole for Suppression of Relapse of Disseminated Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome[NCT00000992] | Phase 1 | 30 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for ketoconazole and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
[Therapy of candidiasis and cryptococcosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cryptococc | 1994 |
Can we prevent azole resistance in fungi?
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resista | 1995 |
Adrenal complications of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex; Adrenal Gland Diseases; AIDS-Related Opportunist | 1994 |
Treatment of coccidioidomycosis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chronic Dis | 1993 |
Pharmacotherapy of disseminated histoplasmosis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; | 1993 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Cand | 1995 |
[Antifungal agent resistance of yeasts of clinical significance].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Dru | 1995 |
Antifungal agents. Part II. The azoles.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Drug Interactions; Fluconazole; Hu | 1999 |
[Exotic pulmonary mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Bla | 1998 |
[American pulmonary histoplasmosis caused by Histoplasma capsulatum].
Topics: Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Asia; Australia; B | 1998 |
[The yeast fungus Malassezia: pathogen, pathogenesis and therapy].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Child; Dermatitis, Atop | 2001 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agen | 2000 |
10 trials available for ketoconazole and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Evaluation and treatment of oral candidiasis in HIV/AIDS patients in Enugu, Nigeria.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adolescent; Adult; Aged; AIDS-Related O | 2008 |
Comparative efficacy of topical therapy with a slow-release mucoadhesive buccal tablet containing miconazole nitrate versus systemic therapy with ketoconazole in HIV-positive patients with oropharyngeal candidiasis.
Topics: Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasi | 2004 |
Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Area Unde | 2007 |
Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Candida; Candidiasis, Oral; Child; C | 1994 |
Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study.
Topics: Adult; AIDS-Related Opportunistic Infections; Candidiasis; Esophagitis; Female; Fluconazole; Follow- | 1994 |
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigen | 1993 |
Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Doubl | 1995 |
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, | 1996 |
Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; H | 1997 |
Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1998 |
47 other studies available for ketoconazole and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Ora | 2007 |
Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 2008 |
Aetiological treatment with itraconazole or ketoconazole in individuals with Trypanosoma cruzi/HIV co-infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Brazil; Chagas Disease; Drug Therapy, Combination; Fat | 2009 |
Azole susceptibility patterns and genetic relationship among oral Candida strains isolated in the era of highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Acti | 2002 |
[Penicilliosis in Laos].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Female; HIV Infections; Humans; Ketoconazo | 2006 |
A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Culture Media; Dermatomycoses; HIV Infecti | 2006 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Oral histoplasmosis in HIV-infected patients. A report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Histoplasmosis; HIV Infections; Humans | 1995 |
Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Cryptococcosis; Cryptococcus neoformans; Cytochrome P-450 Enz | 1995 |
Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Utilization; Hospital | 1994 |
Fluconazole-resistant Candida in AIDS patients. Report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; Drug Resistance, | 1993 |
Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chagas Disease; Dr | 1993 |
Cryptococcosis in an AIDS patient: itraconazole efficacy after other therapeutic failures.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Itraconazole; Ketoconazole; | 1993 |
A banner year for AIDS therapy.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antitubercular Agents; Atovaquone; HIV Inf | 1993 |
Renal aspergilloma in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspe | 1993 |
Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; A | 1993 |
Cost-effective treatment of Candida esophagitis.
Topics: AIDS-Related Opportunistic Infections; Candidiasis; Esophagitis; Humans; Ketoconazole | 1993 |
Azole drug resistance in yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Micr | 1995 |
[African histoplasmosis in a patient with HIV-2 infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; | 1996 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; C | 1996 |
Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; CD4 Lymphocyte Count; C | 1996 |
Rationalizing prescribing for oral and oesophageal candidiasis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Costs | 1996 |
HIV-related skin diseases.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Humans | 1996 |
Oral histoplasmosis associated with candidiasis in HIV-infected patients: a report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Female; Histopla | 1997 |
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Biological Transport; Cand | 1997 |
Ketoconazole resistant oral candidiasis in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 1997 |
Empirical treatment for PCP in HIV-infected patients--justified?
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; HIV Infectio | 1995 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidias | 1997 |
Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistanc | 1997 |
Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug | 1997 |
[Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Or | 1997 |
Clinical predictors of azole resistance, outcome and survival from oesophageal candidiasis in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Body Weight; Candidiasis; CD4 Lymphocyte C | 1998 |
Extragenital donovanosis in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal Agents; Facial Derma | 1998 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albi | 1998 |
Biotypes of oral Candida albicans isolated from AIDS patients and HIV-free subjects in Thailand.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Candida albicans; Candidiasis, Oral; Dose-Res | 2000 |
Cryptococcal osteomyelitis of the spine.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agent | 1999 |
Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Child; Dru | 2001 |
Candidiasis at ICAAC.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Biological Availabil | 1995 |
Histoplasmosis: update 1998.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Dis | 1998 |
[Endemic mycotic infections].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Cocc | 2001 |
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agent | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; | 2001 |
Multicenter Brazilian study of oral Candida species isolated from AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidia | 2002 |
[Candida infection of the skin and mucous membranes still a topic. Administering azoles with clinical understanding].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Can | 2002 |
Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Esophageal Disea | 1992 |
Penicillium marneffei infection in patients infected with human immunodeficiency virus: late presentation in an area of nonendemicity.
Topics: Adult; AIDS-Related Opportunistic Infections; Dermatomycoses; Humans; Itraconazole; Ketoconazole; Ma | 1992 |
The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals.
Topics: AIDS-Related Opportunistic Infections; Blotting, Southern; Candida albicans; Candidiasis; DNA, Funga | 1992 |